New PSA guidelines discourage overscreening

Journal of the National Cancer Institute

Volumn 104, Issue 1, 2012, Pages 8-9

  Peres, Judy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CLINICAL DECISION MAKING; EARLY DIAGNOSIS; HUMAN; LAW SUIT; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PUBLIC HEALTH; RISK ASSESSMENT; RISK BENEFIT ANALYSIS;

DECISION MAKING; EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; HUMANS; MALE; PHYSICIAN-PATIENT RELATIONS; PRACTICE GUIDELINES AS TOPIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 84855485787     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr539     Document Type: Note

References (0)